Avista Healthcare Public Acquisition Corp.
BalancedAHPA·US·🇺🇸 US
54%buys·46%sells
1,314 transactions$504.2MTotal buys·291 buys
$905.8MTotal sells·251 sells
4646 insiders
Last: Dec 16, 2025
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Dec 16, 25 | NUSSDORF GLENN H | Sell | $1.0M | |
| Nov 26, 25 | NUSSDORF GLENN H | Sell | $994K | |
| Nov 25, 25 | NUSSDORF GLENN H | Sell | $64K | |
| Nov 24, 25 | NUSSDORF GLENN H | Sell | $534K | |
| Aug 11, 25 | Grow Brian | Exercise | - | |
| Aug 11, 25 | Grow Brian | Exercise | $10K | |
| Aug 11, 25 | Grow Brian | Other | $10K | |
| Jul 16, 25 | Cavorsi Robert | Other | $2K | |
| Jun 10, 25 | NUSSDORF GLENN H | Sell | $66K | |
| Jun 9, 25 | NUSSDORF GLENN H | Sell | $15K |
Avista Healthcare Public Acquisition Corp. has seen a surge in insider activity with 4 transactions in the last 30 days, compared to a monthly average of 1. Total insider buying volume stands at $504.2M, while selling volume is $905.8M. Insider activity shows a balanced mix of buying and selling.
Avista Healthcare Public Acquisition Corp. (AHPA) has recorded 1,314 insider operations, including 291 open-market purchases ($504.2M), 251 sales ($905.8M) and 772 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is balanced.
Insider activity at Avista Healthcare Public Acquisition Corp. is sustained, with operations recorded in 10 of the last 12 months — a sign of regular regulatory filings.
Among the most active insiders are Burgstahler David F (CEO), Gillheeney Gary S. (CEO) & Avista Acquisition Corp. (CEO), with respectively 132, 111, 29 transactions.
Across all 1,314 recorded transactions, the breakdown by type is: buys (291, 22%), sells (251, 19%), grant (198, 15%), gift (196, 15%), other (134, 10%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Avista Healthcare Public Acquisition Corp. has recorded 1,314 insider operations in total, including 291 open-market purchases ($504.2M), 251 sales ($905.8M) and 772 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on December 16, 2025.
Insiders at Avista Healthcare Public Acquisition Corp. show balanced activity with 54% purchases and 46% sales. Total buy volume is $504.2M versus $905.8M in sales.
InsiderLens tracks 46 insiders at Avista Healthcare Public Acquisition Corp. (AHPA). Burgstahler David F (CEO, 132 tx), Gillheeney Gary S. (CEO, 111 tx), Avista Acquisition Corp. (CEO, 29 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for AHPA is neutral, based on a 54% buy ratio across 542 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Avista Healthcare Public Acquisition Corp. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.